| NF-κB | Nuclear factor κB |
| IKK | IκB kinase |
| Perez-Ruiz | T-lymphocyte associated protein |
| B7 | Ligand for CTLA-4 |
| Treg | Regulatory T cell |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | programmed-death ligand 1 |
| TME | Tumor microenvironment |
| IFN | Interferon |
| IL-17 | Interleukin-17 |
| TNFα | Tumor necrosis factor α |
| TLR | Toll-like receptor |
| PAMPs | Pathogen-associated molecular patterns |
| LPS | Lipopolysaccharide |
| DC | Dendritic cell |
| JAK | Janus kinase |
| STAT | Signal transducer and activation of transcription |
| EBV | Epstein–Barr virus |
| LMP1 | Latent membrane protein 1 |
| HCC | Hepatocellular carcinoma cells |
| NSCLC | Non-small cell lung carcinoma |
| Bcl3 | B cell lymphoma 3 |
| Muc1 | Mucin1 |
| RB | Retinoblastoma |
| CDK | Cyclin-dependent kinase |
| EGFR | Epidermal growth factor receptor |
| HIF-1α | Hypoxia-induced factor 1α |
| EGFR-TKI | EGFR-tyrosine kinase inhibitors |
| CSN5 | Fifth element of the COP9 signalosome |
| COP9 | Constitutive photomorphogenesis 9 |
| COPS5 | COP9 signalosome complex subunit 5 |
| mAb | Monoclonal antibody |
| PTXF | Pentoxifylline |
| COX-2 | Cyclooxygenase-2 |
| Andro | Andrographolide |